Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1959 | 2406 | 34.2 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
551 | 3 | FABRY DISEASE//GAUCHER DISEASE//LYSOSOMAL STORAGE DISEASE | 18099 |
491 | 2 | GAUCHER DISEASE//LYSOSOMAL STORAGE DISEASE//MUCOPOLYSACCHARIDOSIS | 15457 |
1959 | 1 | GAUCHER DISEASE//GLUCOCEREBROSIDASE//GAUCHER CLIN | 2406 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GAUCHER DISEASE | authKW | 8645048 | 35% | 80% | 847 |
2 | GLUCOCEREBROSIDASE | authKW | 2521977 | 10% | 84% | 238 |
3 | GAUCHER CLIN | address | 1307587 | 5% | 79% | 130 |
4 | IMIGLUCERASE | authKW | 537014 | 2% | 92% | 46 |
5 | ENZYME REPLACEMENT THERAPY | authKW | 457050 | 8% | 20% | 181 |
6 | SECT MOL NEUROGENET | address | 404149 | 2% | 56% | 57 |
7 | ALGLUCERASE | authKW | 279170 | 1% | 100% | 22 |
8 | GBA | authKW | 242854 | 1% | 55% | 35 |
9 | BETA GLUCOCEREBROSIDASE | authKW | 231249 | 1% | 68% | 27 |
10 | VELAGLUCERASE ALFA | authKW | 216388 | 1% | 95% | 18 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Genetics & Heredity | 5769 | 21% | 0% | 510 |
2 | Hematology | 4088 | 13% | 0% | 317 |
3 | Medicine, Research & Experimental | 2198 | 12% | 0% | 294 |
4 | Endocrinology & Metabolism | 1009 | 9% | 0% | 217 |
5 | Pediatrics | 759 | 7% | 0% | 170 |
6 | Clinical Neurology | 678 | 9% | 0% | 211 |
7 | Medicine, General & Internal | 677 | 9% | 0% | 224 |
8 | Biochemistry & Molecular Biology | 567 | 17% | 0% | 407 |
9 | Medical Laboratory Technology | 393 | 2% | 0% | 57 |
10 | Pathology | 242 | 4% | 0% | 85 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GAUCHER CLIN | 1307587 | 5% | 79% | 130 |
2 | SECT MOL NEUROGENET | 404149 | 2% | 56% | 57 |
3 | MED GENET BRANCH | 97834 | 3% | 11% | 71 |
4 | DEV METAB NEUROL BRANCH | 96454 | 2% | 19% | 41 |
5 | ENZYMOL CELLULAR FUNCT | 66275 | 1% | 33% | 16 |
6 | LYSOSOMAL STORAGE DISORDERS UNIT | 53596 | 1% | 33% | 13 |
7 | GAUCHER DIS TREATMENT | 50758 | 0% | 100% | 4 |
8 | DIAGNOST GENET BIOCHIM MALATTIE METAB | 45109 | 0% | 44% | 8 |
9 | LYSOSOMAL DISORDERS TREATMENT PROGRAM | 38069 | 0% | 100% | 3 |
10 | NW ONCOL HEMATOL ASSOCIATES PA | 38069 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BLOOD CELLS MOLECULES AND DISEASES | 115266 | 5% | 7% | 127 |
2 | JOURNAL OF INHERITED METABOLIC DISEASE | 29061 | 4% | 2% | 102 |
3 | MOLECULAR GENETICS AND METABOLISM | 23397 | 3% | 2% | 76 |
4 | BAILLIERES CLINICAL HAEMATOLOGY | 6048 | 0% | 4% | 12 |
5 | ORPHANET JOURNAL OF RARE DISEASES | 4090 | 1% | 2% | 19 |
6 | AMERICAN JOURNAL OF HEMATOLOGY | 2865 | 2% | 1% | 37 |
7 | CLINICAL GENETICS | 2193 | 1% | 1% | 30 |
8 | HUMAN MUTATION | 1800 | 1% | 1% | 24 |
9 | MOVEMENT DISORDERS | 1701 | 1% | 0% | 30 |
10 | AMERICAN JOURNAL OF HUMAN GENETICS | 1664 | 1% | 0% | 33 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GAUCHER DISEASE | 8645048 | 35% | 80% | 847 | Search GAUCHER+DISEASE | Search GAUCHER+DISEASE |
2 | GLUCOCEREBROSIDASE | 2521977 | 10% | 84% | 238 | Search GLUCOCEREBROSIDASE | Search GLUCOCEREBROSIDASE |
3 | IMIGLUCERASE | 537014 | 2% | 92% | 46 | Search IMIGLUCERASE | Search IMIGLUCERASE |
4 | ENZYME REPLACEMENT THERAPY | 457050 | 8% | 20% | 181 | Search ENZYME+REPLACEMENT+THERAPY | Search ENZYME+REPLACEMENT+THERAPY |
5 | ALGLUCERASE | 279170 | 1% | 100% | 22 | Search ALGLUCERASE | Search ALGLUCERASE |
6 | GBA | 242854 | 1% | 55% | 35 | Search GBA | Search GBA |
7 | BETA GLUCOCEREBROSIDASE | 231249 | 1% | 68% | 27 | Search BETA+GLUCOCEREBROSIDASE | Search BETA+GLUCOCEREBROSIDASE |
8 | VELAGLUCERASE ALFA | 216388 | 1% | 95% | 18 | Search VELAGLUCERASE+ALFA | Search VELAGLUCERASE+ALFA |
9 | TYPE 1 GAUCHER DISEASE | 203736 | 1% | 94% | 17 | Search TYPE+1+GAUCHER+DISEASE | Search TYPE+1+GAUCHER+DISEASE |
10 | GAUCHER | 182710 | 1% | 60% | 24 | Search GAUCHER | Search GAUCHER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HRUSKA, KS , LAMARCA, ME , SCOTT, CR , SIDRANSKY, E , (2008) GAUCHER DISEASE: MUTATION AND POLYMORPHISM SPECTRUM IN THE GLUCOCEREBROSIDASE GENE (GBA).HUMAN MUTATION. VOL. 29. ISSUE 5. P. 567-583 | 146 | 94% | 160 |
2 | MIGDALSKA-RICHARDS, A , SCHAPIRA, AHV , (2016) THE RELATIONSHIP BETWEEN GLUCOCEREBROSIDASE MUTATIONS AND PARKINSON DISEASE.JOURNAL OF NEUROCHEMISTRY. VOL. 139. ISSUE . P. 77 -90 | 91 | 82% | 4 |
3 | HOROWITZ, M , ELSTEIN, D , ZIMRAN, A , GOKER-ALPAN, O , (2016) NEW DIRECTIONS IN GAUCHER DISEASE.HUMAN MUTATION. VOL. 37. ISSUE 11. P. 1121 -1136 | 150 | 64% | 0 |
4 | MISTRY, PK , LOPEZ, G , SCHIFFMANN, R , BARTON, NW , WEINREB, NJ , SIDRANSKY, E , (2017) GAUCHER DISEASE: PROGRESS AND ONGOING CHALLENGES.MOLECULAR GENETICS AND METABOLISM. VOL. 120. ISSUE 1-2. P. 8 -21 | 107 | 85% | 0 |
5 | GOKER-ALPAN, O , (2011) THERAPEUTIC APPROACHES TO BONE PATHOLOGY IN GAUCHER DISEASE: PAST, PRESENT AND FUTURE.MOLECULAR GENETICS AND METABOLISM. VOL. 104. ISSUE 4. P. 438 -447 | 98 | 94% | 19 |
6 | DEEGAN, PB , COX, TM , (2012) IMIGLUCERASE IN THE TREATMENT OF GAUCHER DISEASE: A HISTORY AND PERSPECTIVE.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 6. ISSUE . P. - | 110 | 84% | 1 |
7 | SIEBERT, M , SIDRANSKY, E , WESTBROEK, W , (2014) GLUCOCEREBROSIDASE IS SHAKING UP THE SYNUCLEINOPATHIES.BRAIN. VOL. 137. ISSUE . P. 1304 -1322 | 110 | 56% | 42 |
8 | MARCUCCI, G , ZIMRAN, A , BEMBI, B , KANIS, J , REGINSTER, JY , RIZZOLI, R , COOPER, C , BRANDI, ML , (2014) GAUCHER DISEASE AND BONE MANIFESTATIONS.CALCIFIED TISSUE INTERNATIONAL. VOL. 95. ISSUE 6. P. 477 -494 | 83 | 95% | 4 |
9 | COX, TM , AERTS, JMFG , BELMATOUG, N , CAPPELLINI, MD , VOM DAHL, S , GOLDBLATT, J , GRABOWSKI, GA , HOLLAK, CEM , HWU, P , MAAS, M , ET AL (2008) MANAGEMENT OF NON-NEURONOPATHIC GAUCHER DISEASE WITH SPECIAL REFERENCE TO PREGNANCY, SPLENECTOMY, BISPHOSPHONATE THERAPY, USE OF BIOMARKERS AND BONE DISEASE MONITORING.JOURNAL OF INHERITED METABOLIC DISEASE. VOL. 31. ISSUE 3. P. 319 -336 | 102 | 81% | 60 |
10 | CONNOCK, M , BURLS, A , FREW, E , FRY-SMITH, A , JUAREZ-GARCIA, A , MCCABE, C , WAILOO, A , ABRAMS, K , COOPER, N , SUTTON, A , ET AL (2006) THE CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF ENZYME REPLACEMENT THERAPY FOR GAUCHER'S DISEASE: A SYSTEMATIC REVIEW.HEALTH TECHNOLOGY ASSESSMENT. VOL. 10. ISSUE 24. P. 1 -+ | 106 | 88% | 32 |
Classes with closest relation at Level 1 |